In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 23rd, 2008 | 29 | Yes |
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.68 | 5.02 | -17.12 | 2 | 8 | 0 | 94 | 400.41 | 7 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 42 | 0.36 | Binding ≤ 10μM |
CP3A4-2-E | Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 1000 | 0.29 | ADME/T ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 42 | 0.36 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 42 | 0.36 | Binding ≤ 10μM |
CP3A4_HUMAN | P08684 | Cytochrome P450 3A4, Human | 1000 | 0.29 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Aflatoxin activation and detoxification | |
EPHA-mediated growth cone collapse | |
Integrin cell surface interactions | |
Neurophilin interactions with VEGF and VEGFR | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation | |
Xenobiotics |